inhibitor Archives - AudioMedica.com

Tagged: inhibitor

0
- in Oncology
- — 26 Apr, 2008
Audio Journal of Oncology Volume 16 Number 9
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam
Angel Rodriguez
In this edition:
1. Lapatinib: Targets Breast Cancer Stem Cells?
Angel Rodriguez, Baylor College, Houston…
Read more
0
- in General Medicine
- — 17 Mar, 2008
New Targets Bring Promise For Lung Cancer Therapy

Egbert Smit
EGBERT SMIT, Free University of Amsterdam
There are a number of promising new molecular targets for lung cancer chemotherapy which were discussed at the Turin congress by Egbert Smit. He talked with Peter Goodwin about insulin-like
…
Read more
0
- in General Medicine
- — 17 Mar, 2008
Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors

Silvia Novello
SILVIA NOVELLO, University of Turin
Future improvements in drug treatment of lung cancer may be made by inhibiting more than one tyrosine kinase simultaneously. So said Silvia Novello when she presented data on a range of drugs
…
Read more
0
- in Oncology
- — 15 Feb, 2008
Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer

David Cunningham
REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
DAVID CUNNINGHAM, Royal Marsden Hospital, London
The oral agent capeticabine is just as effective as fluorouracil for treating patients whose metastatic colorectal cancer
…
Read more
0
- in Oncology
- — 15 Dec, 2007
ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up

Jack Cuzick
JACK CUZICK, Wolfson Institute of Preventive Medicine, London
New data from the ATAC trial, which is testing anastrozole and tamoxifen in early breast cancer, have demonstrated the continued superiority of the aromatase inhibitor. Among other things, the data
…
Read more
0
- in Cardiovascular
- — 5 Nov, 2007
Eptifibatide After PCI: Brief Infusion Is Just As Good

Anthony Fung
REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
ANTHONY FUNG, University of British Columbia, Vancouver
Brief courses of antiplatelet therapy with the glycoprotein 2b 3a inhibitor are just as
…
Read more
0
- in General Medicine
- — 19 Sep, 2007
Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses

Georg Härter
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
GEORG HÄRTER, University Hospital, Ulm
For patients with multiple myeloma being treated with the proteasome inhibitor bortezomib, doctor’s should be wary of viral reactivation – and
…
Read more
0
- in Oncology
- — 31 Aug, 2007
KRAS Mutation: Powerful Molecular Predictor of Cetuximab Response in Patients With Metastatic Colorectal Cancer

Pierre Laurent-Puig

Bill Hait
REFERENCE: ABSTRACT: 5671, American Association for Cancer Research, April 14-18, 2007, Los Angeles
PIERRE LAURENT-PUIG, Hôpital Européen Georges Pompidou, Paris
COMMENT: BILL HAIT, Johnson & Johnson, Raritan, NJ
The presence of the KRAS mutation in tumor
…
Read more
0
- in Oncology
- — 15 Aug, 2007
Virus Plus Cytokine Fight Primary and Metastatic Cancer

Paul Fisher
REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles
PAUL FISHER, Columbia University, New York
Patients with cancer could soon be treated with adenoviruses capable of infecting both primary and distant tumors, and simultaneously releasing cancer-fighting cytokines, according
…
Read more
0
- in Cardiovascular
- — 27 Mar, 2007
Direct Renin Inhibitor Combined with Angiotensin Receptor Blockade Gives Additional Blood Pressure Lowering
SUZANNE OPARIL, University of Alabama, Birmingham
REFERENCE: Abstract 405-12, American College of Cardiolgy New Orleans
A combination of two antihypertensive agents has given improved blood pressure control in a study with nearly 2000 patients reported to the ACC meeting in
…
Read more

Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone

in Public Health
— 6 Mar, 2007

Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone

Roy Steigbigel

ROY STEIGBIGEL, State University of New York at Stony Brook
JOHN W. MELLORS, University of Pittsburgh

REFERENCE: Abstract 105aLB, 105bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
Raltegravir doubled the antiviral response rate and the

…

ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando

in ASCO · Oncology
— 3 Feb, 2007

ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando

Francis Giles

Francis Giles

Ken Kaushansky

Ken Kaushansky

Heather Leitch

Heather Leitch

Nancy Berliner

Nancy Berliner

Corrado Tarella

Corrado Tarella

Vincent Rajkumar

Vincent Rajkumar

Robert Kyle

Robert Kyle

Aurora Kinase BCR-ABL Inhibitor Beats T315-I Mutation in Patients with Chronic Myeloid Leukemia

REFERENCE: Abstract: 163
FRANCIS GILES, M D Anderson Cancer Center, Houston
COMMENT: KEN

…